Goldman Sachs Upgrades BioNTech to Buy, Sees Strong Cancer Therapy Potential
Goldman Sachs raises BioNTech to Buy, citing its strong position in oncology and upcoming 2026 data that could boost new cancer therapies.
NOTRELOAD AI
AST SpaceMobile Wins U.S. Military Defense SHIELD Contract
AST SpaceMobile awarded prime contractor status for MDA's SHIELD missile defense program under Trump's Golden Dome strategy, validating dual-use satellite technology.
Morgan Stanley Turns Bullish on Rocket Lab as Space Tech Gains Momentum
Morgan Stanley upgrades Rocket Lab to Overweight, raising its price target to $105 and highlighting strong growth prospects for the space technology sector in 2026.
FDA Grants Orphan Drug Status to (Z)-Endoxifen for Duchenne Muscular Dystrophy
Atossa Therapeutics receives FDA orphan drug designation for (Z)-endoxifen to treat Duchenne muscular dystrophy, a rare genetic muscle-wasting disease.
Brazil Shuts Down Sigma Lithium Waste Piles Over Safety Concerns
Brazil's Labor Ministry closes three waste piles at Sigma Lithium's flagship mine, citing safety risks. The shutdown adds pressure to the struggling lithium producer's restart efforts.
Barclays Turns Bearish on HP, Sees Further Downside
Barclays downgraded HP to Underweight, cutting its price target to $18, citing weak PC and printing demand and limited growth catalysts.